Cary Adams in WEF Agenda: How to improve access to cancer medicines in LMICs

In this opinion piece published in The Agenda by the World Economic Forum, Dr Cary Adams, CEO of UICC, looks at how public-private partnerships can help ensure a more sustainable access.

In 2020, 70% of the 10 million estimated deaths due to cancer occurred in low and middle-income countries (LMICs). If left unchecked, the number of premature deaths caused by cancer is expected to rise to four million by 2040.

Many LMICs do not have the required health systems infrastructure to adequately treat and care for people with cancer because diagnostics, medicines and other services for comprehensive cancer care are simply not available.

Read the full opinion piece on the World Economic Forum Agenda

Tags Essential medicines Essential Medicines List (EML)

Last update

Monday 11 April 2022

Related content

Collage of four women from different countries

As Breast Cancer Awareness Month focuses global attention on the disease, recent case studies produced by the ATOM Coalition highlight the stark survival gap facing women in low- and middle-income countries (LMICs).

WHO’s new guidelines call on countries to remove legal and systemic barriers to essential pain relief while safeguarding against misuse.